SLC25A11 and neoplasm: Strikingly, a marked reduction in SLC25A11 expression was detected in tumor samples carrying the c.293G>A variant (0.69 ± 0.003) compared to cluster 1 (1.39 ± 0.45; P = .0229) and cluster 2 tumors (1.79 ± 0.71; P = .0154) (Fig. 3A).